Skip Nav Destination
Close Modal
By
Sharon R. Kaufman
Search Results for
medical cost reimbursement
Update search
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Book Series
Date
Availability
1-3 of 3
Search Results for medical cost reimbursement
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... Medicare treatment standards Big Pharma medical cost reimbursement ...
Book Chapter
The Medical-Industrial Complex II Access, Industry, and the Clinical Trials Phenomenon
Available to PurchaseSeries: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
DOI: 10.1215/9780822375500-004
EISBN: 978-0-8223-7550-0
...: the fact that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments. Medicare treatment standards Big Pharma medical cost reimbursement ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments. Medicare treatment standards Big Pharma medical cost reimbursement This chapter turns to the Medicare insurance system, whose...
